80
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus

, , , &
Pages 703-707 | Published online: 26 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ronak Savla, Jeff Browne, Vincent Plassat, Kishor M. Wasan & Ellen K. Wasan. (2017) Review and analysis of FDA approved drugs using lipid-based formulations. Drug Development and Industrial Pharmacy 43:11, pages 1743-1758.
Read now
Min Liu, Meiwan Chen & Zhiwen Yang. (2017) Design of amphotericin B oral formulation for antifungal therapy. Drug Delivery 24:1, pages 1-9.
Read now

Articles from other publishers (13)

Mudassar Shahid, Afzal Hussain, Azmat Ali Khan, Amer M. Alanazi, Ahmed L. Alaofi, Mahboob Alam & Mohhammad Ramzan. (2022) Antifungal Cationic Nanoemulsion Ferrying Miconazole Nitrate with Synergism to Control Fungal Infections: In Vitro , Ex Vivo , and In Vivo Evaluations . ACS Omega 7:15, pages 13343-13353.
Crossref
Kishor M. Wasan. (2020) Development of an Oral Amphotericin B Formulation as an Alternative Approach to Parenteral Amphotericin B Administration in the Treatment of Blood-Borne Fungal Infections. Current Pharmaceutical Design 26:14, pages 1521-1523.
Crossref
Dolores R. Serrano & Aikaterini Lalatsa. (2017) Oral amphotericin B: The journey from bench to market. Journal of Drug Delivery Science and Technology 42, pages 75-83.
Crossref
Raquel Fernández-García, Esther de Pablo, María Paloma Ballesteros & Dolores R. Serrano. (2017) Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting. International Journal of Pharmaceutics 525:1, pages 139-148.
Crossref
Guillaume Desoubeaux & Carolyn Cray. (2017) Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization. Frontiers in Microbiology 8.
Crossref
Masami Ukawa, Hidenori Ando, Taro Shimizu & Tatsuhiro Ishida. 2016. Nanomaterials in Pharmacology. Nanomaterials in Pharmacology 219 238 .
Kuldeep Singh, A.K. Tiwary & Vikas Rana. (2013) Spray dried chitosan–EDTA superior microparticles as solid substrate for the oral delivery of amphotericin B. International Journal of Biological Macromolecules 58, pages 310-319.
Crossref
Juan J TorradoDolores R Serrano & Ijeoma F Uchegbu. (2013) The oral delivery of amphotericin B. Therapeutic Delivery 4:1, pages 9-12.
Crossref
Sanyog Jain, Pankaj U. Valvi, Nitin K. Swarnakar & Kaushik Thanki. (2012) Gelatin Coated Hybrid Lipid Nanoparticles for Oral Delivery of Amphotericin B. Molecular Pharmaceutics 9:9, pages 2542-2553.
Crossref
Jagdishbhai L. Italia, Andrew Sharp, Katharine C. Carter, Peter Warn & M. N. V. Ravi Kumar. (2011) Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome® or Fungizone™. PLoS ONE 6:10, pages e25744.
Crossref
P. Gershkovich, E. K. Wasan, M. Lin, O. Sivak, C. G. Leon, J. G. Clement & K. M. Wasan. (2009) Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. Journal of Antimicrobial Chemotherapy 64:1, pages 101-108.
Crossref
Kishor M. Wasan, Sheila J. Thornton, Ian Bell, Rebecca E. Goulding, Michael Gretes, Andrew P. Gray, Robert E.W. Hancock & Barbara Campbell. (2009) The Global Access Initiative at the University of British Columbia (UBC): Availability of UBC Discoveries and Technologies to the Developing World. Journal of Pharmaceutical Sciences 98:3, pages 791-794.
Crossref
Kristina Sachs-Barrable, Stephen D. Lee, Ellen K. Wasan, Sheila J. Thornton & Kishor M. Wasan. (2008) Enhancing drug absorption using lipids: A case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections. Advanced Drug Delivery Reviews 60:6, pages 692-701.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.